Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Immunogen sequence: DYNIHYLYYW LKHHYNVHFN GLECKTPEEY KGWSVGKYIR SYYEECPKDK LPAYPESFDQ DTEDDEWEKK HRDHTAKKQS VII
Highest antigen sequence indentity to the following orthologs: Rat - 88%, Mouse - 88%.
Leucine-rich repeat-containing protein 17 (LRRC17) is an LRR protein predominantly expressed by osteoblasts. LRRC17 acts as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation. It has been reported that low plasma level of LRRC17 is an independent risk factor for osteoporotic fractures.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Leucine-rich repeat-containing protein 17; p37NB
基因别名: LRRC17; P37NB; UNQ3076/PRO9909
Entrez Gene ID: (Human) 10234